RxDoctor Payments Data

William Morrissette, MD

Family Medicine · Midlothian, VANPI 1245281005

Payments from drug & device makers

$10,348in general payments, 2019–2025

Across 669 payments — averaging $15.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$1K
  • Novo Nordisk$796
  • Lilly USA, LLC$767
  • AstraZeneca$614
  • Boehringer Ingelheim$583
  • plus $5K from 49 others

What the payments were for

  • Food & beverage$10,27099%
  • Education$791%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)116$1,718
Amgen(2 entities)69$1,088
Novo Nordisk54$796
Lilly USA, LLC56$767
AstraZeneca25$614
Boehringer Ingelheim37$583
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC33$523
GSK39$431
Takeda Pharmaceuticals U.S.A., Inc.32$373
Pfizer23$341
Astellas Pharma US Inc14$245
Merck15$232
Corium, LLC8$199
Biohaven Pharmaceuticals, Inc.8$168
Biohaven Pharmaceutical Holding Company Ltd.8$164
Amarin Pharma, Inc.8$157
Abbott8$138
Exact Sciences7$132
Kowa Pharmaceuticals America, Inc.9$128
Johnson & Johnson14$121
Teva Pharmaceuticals USA, Inc.7$114
Novartis6$105
Boston Scientific6$103
Eisai Inc.5$96
Esperion Therapeutics, Inc.6$95
Actelion Pharmaceuticals US, Inc.5$83
Endo Pharmaceuticals Inc.5$72
Genentech USA, Inc.5$62
Shire North American Group Inc5$61
AMAG Pharmaceuticals, Inc.3$52
Otsuka America Pharmaceutical, Inc.2$50
Daiichi Sankyo Inc.2$50
Nalpropion Pharmaceuticals LLC2$37
Mylan Specialty L.p.2$34
Axsome Therapeutics, Inc.2$28
Phathom Pharmaceuticals, Inc.1$27
Amneal Pharmaceuticals LLC2$26
Dynavax Technologies Corporation1$25
Avanir Pharmaceuticals, Inc.2$24
Sumitomo Pharma America, Inc.1$24
Scilex Pharmaceuticals Inc.2$24
Inspire Medical Systems, Inc.1$22
Impulse Dynamics (USA) Inc.1$21
Medtronic1$20
Philips North America LLC1$20
Idorsia Pharmaceuticals US Inc1$20
Sun Pharmaceutical Industries Inc.1$18
Ardelyx, Inc.1$17
Gilead1$17
Nestle Healthcare Nutrition Inc.1$16
Optinose US, Inc.1$14
Edwards Lifesciences1$13
Currax Pharmaceuticals LLC1$13
Ironshore Pharmaceuticals Inc.1$12
Ultragenyx Pharmaceutical Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,348 in reported general payments places this provider in the 90th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$130,404
Medicare patients
552
Services billed
2,250

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban67$65,823
FarxigaDapagliflozin Propanediol65$53,711
OzempicSemaglutide34$28,081
XareltoRivaroxaban25$22,702
MounjaroTirzepatide20$20,350
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,518
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog17$6,967
Rosuvastatin Calcium378$5,121
SynthroidLevothyroxine Sodium53$3,760
Ezetimibe121$3,493
Levothyroxine Sodium264$2,806
Bupropion XlBupropion Hcl81$2,357
Celecoxib60$2,280
Estradiol20$2,224
Verapamil SrVerapamil Hcl15$2,106

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$341$67,25278 claims
AstraZenecaFarxiga$614$53,71165 claims
Novo NordiskOzempic$796$28,08134 claims
Johnson & JohnsonXarelto$121$22,70225 claims
Lilly USA, LLCMounjaro$767$20,35020 claims
GSKTrelegy Ellipta$431$7,51812 claims
AbbVieSynthroid$1,718$3,76053 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$26$2,806264 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Midlothian

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →